Filing Details
OCULAR THERAPEUTIX, INC (NASDAQ:OCUL) filed a Form 8-K with the Securities and Exchange Commission on November 09, 2026, disclosing a material event.
8k filedNASDAQ:OCUL
OCULAR THERAPEUTIX, INC (OCUL) Reports Material Event to SEC
OCULAR THERAPEUTIX, INC (NASDAQ:OCUL) filed a Form 8-K with the Securities and Exchange Commission on November 09, 2026, disclosing a material event.
At publication ·
What changed
OCULAR THERAPEUTIX, INC (NASDAQ:OCUL) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Ocular Therapeutix filed a Form 8-K on November 9, 2026, disclosing a material event to shareholders.
- The company's stock trades at $6.59 with a market capitalization of $2.5 billion.
- Material events reported via 8-K can include leadership changes, agreements, acquisitions, or asset sales.
Market Context
OCULAR THERAPEUTIX, INC's stock currently trades at $6.59 with a market capitalization of $2.5B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for OCULAR THERAPEUTIX, INC's stock.
All SEC filings for OCULAR THERAPEUTIX, INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View OCUL Stock Page
Frequently Asked Questions
Where can I read OCUL's SEC filings?
Browse all filings on our OCUL SEC filings page.
What types of SEC filings does OCULAR THERAPEUTIX, INC file?
Public companies like OCULAR THERAPEUTIX, INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
